Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer

Tamoxifen therapy resistance constitutes a major cause of death in patients with recurrent estrogen receptor (ER) positive breast cancer. Through high resolution mass spectrometry (MS), we previously generated a 4-protein predictive signature for tamoxifen therapy outcome in recurrent breast cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: De Marchi, Tommaso, Timmermans, Anne M., Smid, Marcel, Look, Maxime P., Stingl, Christoph, Opdam, Mark, Linn, Sabine C., Sweep, Fred C. G. J., Span, Paul N., Kliffen, Mike, van Deurzen, Carolien H. M., Luider, Theo M., Foekens, John A., Martens, John W., Umar, Arzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823093/
https://www.ncbi.nlm.nih.gov/pubmed/26657294
http://dx.doi.org/10.18632/oncotarget.6521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823093/
https://www.ncbi.nlm.nih.gov/pubmed/26657294
http://dx.doi.org/10.18632/oncotarget.6521

Ejemplares similares